IBEX Reports Record Q2 Revenue & EPS, Raises Full-Year Guidance
IBEX sits 62% above its 52-week low of $21.64 on elevated volume (3.1× avg).
Summary
IBEX Ltd announced record second fiscal quarter results, with revenue up 16.7% and adjusted EPS up 46.3%, leading the company to raise its full-year fiscal 2026 revenue and adjusted EBITDA guidance.
Key Events · Earnings and Guidance · IBEX
-
Record Quarterly Performance
IBEX reported record second fiscal quarter revenue of $164.2 million, a 16.7% increase year-over-year, and record diluted EPS of $0.83, up 44.9%.
-
Strong Profitability Growth
Adjusted EBITDA increased by 25.2% to $20.7 million, with adjusted EPS growing 46.3% to $0.87, driven by higher margin offshore regions and efficient cost management.
-
Raised Fiscal Year 2026 Guidance
The company raised its fiscal year 2026 revenue guidance to a range of $620-$630 million (from $605-$620 million) and adjusted EBITDA guidance to $80-$82 million (from $78-$81 million).
-
Strategic Investments
IBEX is making opportunistic investments in AI solutions and increasing sales resources and capacity in top-performing geographies to extend its leadership position.
Analysis · IBEX · Technology
IBEX Ltd delivered a strong second fiscal quarter, reporting record revenue and earnings per share, alongside a significant increase in adjusted EBITDA. The company's revenue growth of 16.7% marks its fourth consecutive quarter of double-digit expansion, driven by strong performance in HealthTech, Travel, Transportation & Logistics, and Retail & E-commerce verticals. The positive momentum is further underscored by the decision to raise full-year fiscal 2026 guidance for both revenue and adjusted EBITDA, indicating management's confidence in continued operational strength and market share gains. Investors should view this as a robust performance, suggesting healthy business fundamentals and an optimistic outlook.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 36.1% of the 1758 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.05%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IBEX was trading at $35.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $460.7M. The 52-week trading range was $21.64 to $42.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.